A new European Commission strategy promises to lift life sciences in the region out of a two-decade slump by tackling ...

French biotech MaaT Pharma has signed a licensing and distribution agreement with UK-based Clinigen, positioning the company ...

The US Food and Drug Administration (FDA) has provided an update on the risk of myocarditis after receiving an mRNA COVID-19 ...

UK-based contract research, development and manufacturing organization Ingenza has named Nick Challoner as its new chief ...

US biopharma Apellis Pharmaceuticals announced a capped royalty purchase agreement with Swedish Orphan Biovitrum where ...

US-Japan venture capital firm AN Venture Partners has wrapped up its first fund at $200 million, marking one of the largest ...

The UK government today launched its 10 Year Health Plan for the National Health Service (NHS), promising a "new era." A new ...

The chronic kidney disease (CKD) anemia market across the seven major markets (7MM) is forecast to grow at a compound annual ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Fruzaqla ...

Swiss pharma giant Novartis has announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx (secukinumab ...

US women’s health focused drugmaker Organon (NYSE: OGN) yesterday revealed disappointing results from the Phase II ELENA ...

The US Food and Drug Administration has granted accelerated approval to sunvozertinib (trade name Zegfrovy) from Dizal ...